November 28, 2024 - 08:51

In a significant move, former President Donald Trump has selected a Stanford University professor known for his critical stance on COVID-19 lockdowns to lead a key health agency. This appointment comes as part of Trump’s ongoing efforts to reshape health policy and address public health challenges in the wake of the pandemic. The professor, who has gained attention for advocating against strict lockdown measures, is expected to bring a controversial perspective to the role.
Before officially assuming the position, the appointee will need to secure confirmation from the U.S. Senate, a process that could spark intense debate given the professor's previous comments and the current political climate surrounding public health policies. Trump's choice reflects his commitment to appointing individuals who align with his views on government intervention and public health measures. As the nation continues to navigate the complexities of health care and pandemic response, this appointment is poised to influence future strategies and discussions within the health sector.
June 16, 2026 - 05:26
Congress must reauthorize the Pandemic and All-Hazards Preparedness ActAmerica`s next health emergency will not wait for Washington to get its act together, according to two former public health officials. W. Craig Vanderwagen and Jennifer B. Alton argue that the...
June 15, 2026 - 19:29
Students with highest distress use AI for mental health at elevated rates, study findsA new study reveals that college students experiencing the highest levels of psychological distress are turning to generative AI for mental health support at significantly higher rates than their...
June 15, 2026 - 01:59
Residents can get a look at new Talent Health Center in late JuneRogue Community Health is opening the doors of its newest clinic in Talent for a public tour later this month. The event gives local residents a first look at the facility before it begins full...
June 14, 2026 - 14:15
Mizuho Raises CVS Health (CVS) Price Target on More Stable Policy EnvironmentMizuho has increased its price target for CVS Health shares, pointing to a more predictable policy environment as a key factor. The financial firm`s analysts now see greater potential for the...